Role of Nutrition and Maternal Genetics on the Programming of Development of Fetal Adipose Tissue (PREOBE)
The Role of Nutrition and Maternal Genetics on the Programming of Development of Fetal Adipose Tissue. Search for Markers of the Obesity Risk in Early Stages of Life
Sponsor: Abbott
A observational or N/A phase clinical study on Diabetes and Obesity, this trial is ongoing. The trial is conducted by Abbott and has accumulated 12 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
▶ Show 7 earlier versions
-
Aug 2019 — Nov 2020 [monthly]
Unknown Status
-
Aug 2018 — Aug 2019 [monthly]
Unknown Status
-
Jun 2018 — Aug 2018 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
-
Apr 2018 — May 2018 [monthly]
Unknown Status
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Unknown Status NA
-
Jan 2017 — Aug 2017 [monthly]
Unknown Status NA
First recorded
Mar 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott
- Andalusian Agency of Knowledge
- ICTAN-CSIC - Madrid - Spain
- Ludwig-Maximilians - University of Munich
- Ministerio de Economía y Competitividad, Spain
- Scottish Government NuGO EU Project
- Universidad de Granada
- University of Aberdeen
- University of Barcelona
- University of Nottingham
For direct contact, visit the study record on ClinicalTrials.gov .